In this edition:
The UK experience of NAET during COVID-19 pandemic
Tailored breast screening in the Netherlands
Is it possible to conquer fear of recurrence?
New genes and what they mean for patients and families
Real world evidence and breast cancer management
The use of topical oestrogen in symptomatic women with EBC
Age and menstrual cycling on gene expression profiling tests
Enhanced toxicity with T-DM1 and concurrent RT
PROSPECT of selective omission of RT based on MRI findings
No association between breast pain and breast cancer
Please login below to download this issue (PDF)